Standard BioTools Shares Outstanding 2010-2025 | LAB
Standard BioTools shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Standard BioTools Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 353 |
| 2023 | 79 |
| 2022 | 78 |
| 2021 | 76 |
| 2020 | 72 |
| 2019 | 67 |
| 2018 | 40 |
| 2017 | 33 |
| 2016 | 29 |
| 2015 | 29 |
| 2014 | 28 |
| 2013 | 25 |
| 2012 | 22 |
| 2011 | 18 |
| 2010 | 2 |
| 2009 | 2 |
| Standard BioTools Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 378 |
| 2024-12-31 | 353 |
| 2024-09-30 | 372 |
| 2024-06-30 | 372 |
| 2024-03-31 | 294 |
| 2023-12-31 | 79 |
| 2023-09-30 | 79 |
| 2023-06-30 | 79 |
| 2023-03-31 | 79 |
| 2022-12-31 | 78 |
| 2022-09-30 | 79 |
| 2022-06-30 | 78 |
| 2022-03-31 | 77 |
| 2021-12-31 | 76 |
| 2021-09-30 | 76 |
| 2021-06-30 | 75 |
| 2021-03-31 | 75 |
| 2020-12-31 | 72 |
| 2020-09-30 | 72 |
| 2020-06-30 | 71 |
| 2020-03-31 | 70 |
| 2019-12-31 | 67 |
| 2019-09-30 | 69 |
| 2019-06-30 | 69 |
| 2019-03-31 | 58 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 39 |
| 2018-03-31 | 39 |
| 2017-12-31 | 33 |
| 2017-09-30 | 35 |
| 2017-06-30 | 29 |
| 2017-03-31 | 29 |
| 2016-12-31 | 29 |
| 2016-09-30 | 29 |
| 2016-06-30 | 29 |
| 2016-03-31 | 29 |
| 2015-12-31 | 29 |
| 2015-09-30 | 29 |
| 2015-06-30 | 29 |
| 2015-03-31 | 28 |
| 2014-12-31 | 28 |
| 2014-09-30 | 28 |
| 2014-06-30 | 28 |
| 2014-03-31 | 27 |
| 2013-12-31 | 25 |
| 2013-09-30 | 26 |
| 2013-06-30 | 25 |
| 2013-03-31 | 25 |
| 2012-12-31 | 22 |
| 2012-09-30 | 23 |
| 2012-06-30 | 21 |
| 2012-03-31 | 20 |
| 2011-12-31 | 18 |
| 2011-09-30 | 20 |
| 2011-06-30 | 20 |
| 2011-03-31 | 11 |
| 2010-12-31 | 2 |
| 2010-09-30 | 2 |
| 2010-06-30 | 2 |
| 2010-03-31 | 2 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.406B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.328B | 59.20 |
| Hims & Hers Health (HIMS) | United States | $12.250B | 127.28 |
| Tempus AI (TEM) | United States | $10.726B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.629B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.081B | 63.76 |
| Hinge Health (HNGE) | United States | $3.147B | 0.00 |
| Privia Health (PRVA) | United States | $2.800B | 191.42 |
| Enovis (ENOV) | United States | $1.753B | 9.77 |
| Schrodinger (SDGR) | United States | $1.680B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 25.64 |
| Azenta (AZTA) | United States | $1.298B | 60.34 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.644B | 0.00 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.584B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 170.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 793.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.50 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |